Ayahuasca for PTSD with Dr. Simon Ruffell MBChB, MRCPsych, PhD

Ayahuasca for PTSD with Dr. Simon Ruffell MBChB, MRCPsych, PhD

Author: Lynn Marie Morski, MD, JD March 4, 2026 Duration: 47:29

In this episode Dr. Simon Ruffell joins to discuss the research on ayahuasca for PTSD. Dr. Ruffell is a psychiatrist, researcher, and student of curanderismo (Amazonian shamanism) working at the intersection of Western psychiatry, traditional plant medicine, and Indigenous knowledge systems. He is Executive Director of Onaya, Lecturer in Psychology and Psychedelics at the University of Exeter, and Chief Medical Officer of MINDS, with a focus on integrative and relational approaches to healing and consciousness.

In this conversation, Dr. Ruffell explores the emerging research on ayahuasca as a treatment for PTSD, drawing on both Western scientific models and Indigenous Shipibo knowledge systems. He outlines how ayahuasca may work through mechanisms such as increased neuroplasticity, disruption of rigid predictive models, and potential epigenetic shifts related to stress and trauma, while emphasizing that these biological explanations exist alongside Indigenous understandings of "cleaning ancestral lines." Sharing preliminary findings from his ongoing research with military veterans in collaboration with Heroic Hearts Project, Dr. Ruffell discusses significant reductions in PTSD symptoms at six-month follow-up, the powerful role of community and ceremony, and the ethical complexities of studying sacred practices through Western scientific tools. He closes with a moving story of a veteran whose healing journey illustrates both the promise and the limits of psychedelic medicine when embedded in relational and cultural context.

 

In this episode, you'll hear:

  • Western scientific theories for how ayahuasca may alleviate PTSD
  • How trauma-related epigenetic changes may be transmitted across generations
  • Preliminary results from Dr. Ruffell's study of ayahuasca for veterans diagnosed with PTSD
  • The role of community bonding and peer support among veterans in maintaining therapeutic gains
  • Why ayahuasca research in the Amazon includes a broader plant-based healing system—not just the brew itself
  • How Indigenous healers interpret epigenetic findings as confirmation of longstanding ancestral frameworks
  • The ethical considerations of bringing Western measurement tools (like EEG) into sacred ceremonial contexts

 

Quotes:

"This is what I find most interesting about our research—that it is cutting edge science but at the same time, when we conduct it with indigenous healers, we get a whole new perspective on what could be happening when it comes to interpreting the results and also making decisions of what to research as well." [14:09]

"According to measures of PTSD on the scales that we're looking at, over 80% of the participants that were scoring for PTSD before their ayahuasca retreats and no longer scoring for PTSD at that six month follow up. So it's not just immediately after the ayahuasca retreats. It's six months later. And that's super, super encouraging." [15:52]

"When we take things to the lab, one of the reasons that we might see the effect size diminishing is because we no longer have shamanism, basically, which is exerting a huge effect." [16:55]

"Traditionally what would happen is that the curandero would drink ayahuasca and the participants would just be there and the curandero would use the visions that they had with ayahuasca to look into the participants and to diagnose them. And then the healing would come through them singing their medicinal chants, which are the icaros. And then afterwards they would give them a prescription of plants or whatever it is that they needed. And sometimes the prescription would be to drink ayahuasca, but most of the time it wouldn't be. [27:18]

"You can't separate like DMT, in my eyes, from the rest of the compounds in ayahuasca, from the ceremony, from the jungle. That, in my opinion, is what makes up Shipibo. Otherwise you just have a bunch of chemicals." [28:20]

 

Links:

Dr. Ruffell's website

Dr. Ruffell on LinkedIn

Dr. Ruffell on Instagram

Onaya website

Onaya Science website

Onaya on LinkedIn

Onaya on Instagram

Previous episode: Can Ayahuasca Heal PTSD? with Former Army Ranger Jesse Gould

Psychedelic Medicine Association

Porangui


Exploring the frontier of mind and medicine, the Psychedelic Medicine Podcast with Dr. Lynn Marie Morski delves into the complex world of psychedelic substances and their potential to heal. Hosted by Lynn Marie Morski, a physician and attorney, this podcast navigates the intricate intersection of cutting-edge science, clinical practice, and evolving policy. Each episode brings a grounded, expert perspective to conversations about psilocybin, MDMA, ketamine, LSD, ayahuasca, ibogaine, and other compounds, moving beyond hype to examine the real-world implications of this therapeutic renaissance. Listeners will hear detailed discussions on the latest peer-reviewed research, practical insights from medical professionals integrating these approaches, and thoughtful analysis of the legal landscape shaping access. The dialogue is rooted in a commitment to safety, ethics, and evidence, offering a clear-eyed look at both the profound promise and the challenges inherent in psychedelic medicine. Whether you're a healthcare provider, a patient, a researcher, or simply intellectually curious, this podcast provides an essential, nuanced resource for understanding how these ancient and modern substances are reshaping perspectives on mental health, consciousness, and treatment. It’s a space for serious inquiry, where complex questions about healing, neuroscience, and society are met with informed, accessible conversation.
Author: Language: English Episodes: 50

Psychedelic Medicine Podcast with Dr. Lynn Marie Morski
Podcast Episodes
Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD [not-audio_url] [/not-audio_url]

Duration: 39:32
In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 years of clinical ex…
Encore Episode: Psychedelics and Breathwork with Kyle Buller [not-audio_url] [/not-audio_url]

Duration: 43:58
This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has studied breathwork…
Psychedelics and Psychosis with Alexander Lebedev, MD, PhD [not-audio_url] [/not-audio_url]

Duration: 46:09
In this episode of the Psychedelic Medicine Podcast, Alexander Lebedev, MD, PhD joins to discuss psychedelic medicine and psychosis. Dr. Lebedev is a physician-scientist, medical AI engineer, and entrepreneur working at…
Psychedelics and GLP-1s with Arsalan Azam, MD [not-audio_url] [/not-audio_url]

Duration: 36:22
In this episode of the Psychedelic Medicine Podcast, Arsalan Azam, MD joins to unpack the intersection between psychedelics and GLP-1s. Dr. Azam, founder of Daydream MD, completed his residency in Emergency Medicine at t…
Psilocybin vs. Ketamine with Dori Lewis, LPC [not-audio_url] [/not-audio_url]

Duration: 43:11
In this episode of the Psychedelic Medicine Podcast, Dori Lewis, MA, MEd, LPC-S returns to discuss the differences between psilocybin and ketamine. Dori is the Clinical Director of Elemental Psychedelics and Owner/Operat…
Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD [not-audio_url] [/not-audio_url]

Duration: 50:19
In this episode of the Psychedelic Medicine Podcast, Katie Fassbinder, MD joins to explore how to choose the right ketamine clinic. Dr. Fassbinder is the Faculty Medical Lead for ketamine-assisted psychotherapy training…
The Future of Psychedelic Medicine with Ismail Lourido Ali, JD [not-audio_url] [/not-audio_url]

Duration: 52:24
In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively participating in the…
Psychedelics and Neurodiversity with Dr. WaiFung Tsang, DClinPsy [not-audio_url] [/not-audio_url]

Duration: 43:31
In this episode, Dr. WaiFung Tsang, DClinPsy joins to discuss the intersection of psychedelics and neurodiversity. Dr. Tsang is a clinical research psychologist from Hong Kong, musician, and student of Shipibo curanderis…